Source: ALL

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 22853
Gene Symbol: LMTK2
LMTK2
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.140 GeneticVariation GWASCAT Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 29892016

2018
Entrez Id: 22853
Gene Symbol: LMTK2
LMTK2
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.140 Biomarker BEFREE Across 66 meta-analyses, a total of 20 genetic variants involving 584,100 subjects in 19 different genes (KLK3, IGFBP3, ESR1, SOD2, CAT, CYP1B1, VDR, RFX6, HNF1B, SRD5A2, FGFR4, LEP, HOXB13, FAS, FOXP4, SLC22A3, LMTK2, EHBP1 and MSMB) exhibited significant association with prostate cancer. 26967244

2016
Entrez Id: 22853
Gene Symbol: LMTK2
LMTK2
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.140 Biomarker BEFREE In addition, LMTK2 knockdown led to an increase in prostate cancer stem cell populations in LNCaP cells, indicative of increased tumorogenicity. 26008968

2015
Entrez Id: 22853
Gene Symbol: LMTK2
LMTK2
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.140 GeneticVariation BEFREE Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer. 20569440

2010
Entrez Id: 22853
Gene Symbol: LMTK2
LMTK2
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.140 GeneticVariation GWASCAT Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. 19767753

2009
Entrez Id: 22853
Gene Symbol: LMTK2
LMTK2
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.140 Biomarker BEFREE The MSMB and KLK2/3 genes may be useful for PCa screening, and the LMTK2 gene might provide a potential therapeutic target. 19050691

2009
Entrez Id: 22853
Gene Symbol: LMTK2
LMTK2
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.140 GeneticVariation GWASCAT Multiple newly identified loci associated with prostate cancer susceptibility. 18264097

2008